Titre : Hépatite auto-immune

Hépatite auto-immune : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cloud Computing
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hépatite auto-immune : Questions médicales les plus fréquentes", "headline": "Hépatite auto-immune : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hépatite auto-immune : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-08", "dateModified": "2025-04-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hépatite auto-immune" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies auto-immunes", "url": "https://questionsmedicales.fr/mesh/D001327", "about": { "@type": "MedicalCondition", "name": "Maladies auto-immunes", "code": { "@type": "MedicalCode", "code": "D001327", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.111" } } }, "about": { "@type": "MedicalCondition", "name": "Hépatite auto-immune", "alternateName": "Hepatitis, Autoimmune", "code": { "@type": "MedicalCode", "code": "D019693", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Ansgar W Lohse", "url": "https://questionsmedicales.fr/author/Ansgar%20W%20Lohse", "affiliation": { "@type": "Organization", "name": "1(st) Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; European Reference Network on Hepatological Diseases (ERN RARE-LIVER)." } }, { "@type": "Person", "name": "Gideon M Hirschfield", "url": "https://questionsmedicales.fr/author/Gideon%20M%20Hirschfield", "affiliation": { "@type": "Organization", "name": "Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, Canada." } }, { "@type": "Person", "name": "Marco Lenzi", "url": "https://questionsmedicales.fr/author/Marco%20Lenzi", "affiliation": { "@type": "Organization", "name": "Department of Medical and Surgical Sciences, Sant'Orsola-Malpighi, University of Bologna, Bologna, Italy." } }, { "@type": "Person", "name": "Christoph Schramm", "url": "https://questionsmedicales.fr/author/Christoph%20Schramm", "affiliation": { "@type": "Organization", "name": "1(st) Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Martin Zeitz Centre for Rare Diseases, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; European Reference Network on Hepatological Diseases (ERN RARE-LIVER)." } }, { "@type": "Person", "name": "Michael A Heneghan", "url": "https://questionsmedicales.fr/author/Michael%20A%20Heneghan", "affiliation": { "@type": "Organization", "name": "Institute of Liver Studies, King's College Hospital, London, United Kingdom; European Reference Network on Hepatological Diseases (ERN RARE-LIVER). Electronic address: michael.heneghan@nhs.net." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Reconstruction of Sparse-View X-ray Computed Tomography Based on Adaptive Total Variation Minimization.", "datePublished": "2023-12-15", "url": "https://questionsmedicales.fr/article/38138414", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/mi14122245" } }, { "@type": "ScholarlyArticle", "name": "Metallic artifacts-free spectral computed tomography angiography based on renal clearable bismuth chelate.", "datePublished": "2023-12-14", "url": "https://questionsmedicales.fr/article/38128318", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.biomaterials.2023.122422" } }, { "@type": "ScholarlyArticle", "name": "Computed tomographic diaphragmatic thickness: a promising method for the evaluation of diaphragmatic muscle in cardiopulmonary diseased cats.", "datePublished": "2023-12-14", "url": "https://questionsmedicales.fr/article/38164391", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fvets.2023.1247531" } }, { "@type": "ScholarlyArticle", "name": "Experimental and Computational Investigation of Microbubble Formation in a Single Capillary Embedded T-junction Microfluidic Device.", "datePublished": "2023-12-12", "url": "https://questionsmedicales.fr/article/38087401", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.langmuir.3c02982" } }, { "@type": "ScholarlyArticle", "name": "Cardiac computed tomography angiography with and without bolus tracking methods in infants with congenital heart disease.", "datePublished": "2023-12-12", "url": "https://questionsmedicales.fr/article/38088430", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1093/rpd/ncad295" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007154" }, { "@type": "ListItem", "position": 3, "name": "Maladies auto-immunes", "item": "https://questionsmedicales.fr/mesh/D001327" }, { "@type": "ListItem", "position": 4, "name": "Hépatite auto-immune", "item": "https://questionsmedicales.fr/mesh/D019693" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hépatite auto-immune - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hépatite auto-immune", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hépatite auto-immune", "description": "Comment diagnostiquer l'hépatite auto-immune ?\nQuels tests sanguins sont utilisés ?\nQuel rôle joue la biopsie dans le diagnostic ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on confondre cette hépatite avec d'autres ?", "url": "https://questionsmedicales.fr/mesh/D019693?mesh_terms=Cloud+Computing&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hépatite auto-immune", "description": "Quels sont les symptômes courants ?\nLa fièvre est-elle un symptôme ?\nLes symptômes varient-ils selon les patients ?\nY a-t-il des symptômes spécifiques chez les femmes ?\nLes symptômes peuvent-ils s'aggraver ?", "url": "https://questionsmedicales.fr/mesh/D019693?mesh_terms=Cloud+Computing&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hépatite auto-immune", "description": "Peut-on prévenir l'hépatite auto-immune ?\nLes vaccinations sont-elles utiles ?\nLe dépistage précoce est-il important ?\nLes habitudes alimentaires influencent-elles ?\nLe stress a-t-il un impact ?", "url": "https://questionsmedicales.fr/mesh/D019693?mesh_terms=Cloud+Computing&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hépatite auto-immune", "description": "Quels traitements sont disponibles ?\nLes traitements sont-ils efficaces ?\nY a-t-il des effets secondaires aux traitements ?\nLe traitement est-il à vie ?\nDes traitements alternatifs existent-ils ?", "url": "https://questionsmedicales.fr/mesh/D019693?mesh_terms=Cloud+Computing&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hépatite auto-immune", "description": "Quelles sont les complications possibles ?\nLa cirrhose est-elle réversible ?\nComment l'insuffisance hépatique se manifeste-t-elle ?\nLe cancer du foie est-il fréquent ?\nDes complications peuvent-elles survenir rapidement ?", "url": "https://questionsmedicales.fr/mesh/D019693?mesh_terms=Cloud+Computing&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hépatite auto-immune", "description": "Quels sont les facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe sexe a-t-il un impact sur le risque ?\nDes facteurs environnementaux sont-ils impliqués ?", "url": "https://questionsmedicales.fr/mesh/D019693?mesh_terms=Cloud+Computing&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'hépatite auto-immune ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins, biopsies hépatiques et évaluation des symptômes." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent les anticorps antinucléaires et les anticorps anti-muscle lisse." } }, { "@type": "Question", "name": "Quel rôle joue la biopsie dans le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "La biopsie permet d'évaluer l'inflammation et les lésions hépatiques au microscope." } }, { "@type": "Question", "name": "Les symptômes aident-ils au diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme la fatigue et la jaunisse orientent vers l'hépatite auto-immune." } }, { "@type": "Question", "name": "Peut-on confondre cette hépatite avec d'autres ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être confondue avec l'hépatite virale ou alcoolique sans tests appropriés." } }, { "@type": "Question", "name": "Quels sont les symptômes courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, jaunisse, douleurs abdominales et démangeaisons." } }, { "@type": "Question", "name": "La fièvre est-elle un symptôme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fièvre peut survenir, souvent accompagnée d'autres symptômes d'inflammation." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon les patients ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la combinaison des symptômes peuvent varier d'un patient à l'autre." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques chez les femmes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les femmes peuvent présenter des symptômes plus marqués, comme des troubles menstruels." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils s'aggraver ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sans traitement, les symptômes peuvent s'aggraver et mener à des complications." } }, { "@type": "Question", "name": "Peut-on prévenir l'hépatite auto-immune ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de prévention spécifique, mais un mode de vie sain peut aider." } }, { "@type": "Question", "name": "Les vaccinations sont-elles utiles ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations contre l'hépatite virale peuvent prévenir des complications hépatiques." } }, { "@type": "Question", "name": "Le dépistage précoce est-il important ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un dépistage précoce peut aider à gérer la maladie avant qu'elle ne progresse." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut soutenir la santé du foie et réduire les risques." } }, { "@type": "Question", "name": "Le stress a-t-il un impact ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut aggraver les symptômes, donc des techniques de gestion du stress sont bénéfiques." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des corticostéroïdes et des immunosuppresseurs pour réduire l'inflammation." } }, { "@type": "Question", "name": "Les traitements sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la plupart des patients répondent bien aux traitements, améliorant leur qualité de vie." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires aux traitements ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les corticostéroïdes peuvent causer des effets secondaires comme la prise de poids." } }, { "@type": "Question", "name": "Le traitement est-il à vie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, mais certains patients nécessitent un traitement à long terme pour contrôler la maladie." } }, { "@type": "Question", "name": "Des traitements alternatifs existent-ils ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des approches complémentaires comme la nutrition peuvent aider, mais nécessitent des études." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la cirrhose, l'insuffisance hépatique et le cancer du foie." } }, { "@type": "Question", "name": "La cirrhose est-elle réversible ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Non, la cirrhose est irréversible, mais un traitement peut ralentir sa progression." } }, { "@type": "Question", "name": "Comment l'insuffisance hépatique se manifeste-t-elle ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par une fatigue extrême, une confusion et des saignements faciles." } }, { "@type": "Question", "name": "Le cancer du foie est-il fréquent ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Le cancer du foie peut survenir chez les patients avec hépatite auto-immune avancée." } }, { "@type": "Question", "name": "Des complications peuvent-elles survenir rapidement ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines complications peuvent se développer rapidement sans traitement approprié." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, le sexe féminin et d'autres maladies auto-immunes." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'hépatite auto-immune est plus fréquente chez les jeunes adultes et les adolescents." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies auto-immunes augmentent le risque d'hépatite auto-immune." } }, { "@type": "Question", "name": "Le sexe a-t-il un impact sur le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes sont plus susceptibles de développer une hépatite auto-immune que les hommes." } }, { "@type": "Question", "name": "Des facteurs environnementaux sont-ils impliqués ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections virales et des toxines environnementales peuvent déclencher la maladie." } } ] } ] }

Sources (10000 au total)

Evaluation of image quality and radiation dose in computed tomography urography following tube voltage optimisation.

Computed tomography urography (CTU) comprehensively evaluates the urinary tract. However, the procedure is associated with a high radiation dose due to multiple scan series and therefore requires opti... The study was prospectively conducted on patients referred for CTU. The patients were grouped into A and B and were scanned with the standard protocol, a protocol used for the routine CTU at the CT ce... The dose was significantly lower in the optimised protocol with a 10 % reduction in both volume computed tomography dose index and (CTDIvol) and dose length product (DLP) for the phantom images, and a... The findings revealed a significant dose reduction in the optimised protocol. Further, image quality in standard and optimised protocols did not differ significantly based on quantitative and qualitat... kV optimisation in contrast-enhanced procedures provides dose reduction and should be encouraged in the medical imaging departments....

Prediction of preoperative microvascular invasion by dynamic radiomic analysis based on contrast-enhanced computed tomography.

Microvascular invasion (MVI) is a common complication of hepatocellular carcinoma (HCC) surgery, which is an important predictor of reduced surgical prognosis. This study aimed to develop a fully auto... A total of 140 patients with HCC from two centers were retrospectively included (training set, n = 98; testing set, n = 42). All CT phases were aligned to the portal venous phase, and were then used t... Overall, 86 and 54 patients with MVI- (age, 55.92 ± 9.62 years; 68 men) and MVI+ (age, 53.59 ± 11.47 years; 43 men) were included. Average dice coefficients of liver tumor segmentation were 0.89 and 0... The classification model based on multimodal intra- and peri-tumoral radiomics features can well predict HCC patients with MVI....

Computer tomography perfusion patterns in iatrogenic cerebral arterial gas embolism: A retrospective cohort study.

Cerebral arterial gas embolism (CAGE) occurs when air or medical gas enters the systemic circulation during invasive procedures and lodges in the cerebral vasculature. Non-contrast computer tomography... This is a retrospective single-center cohort study. We included patients who were diagnosed with iatrogenic CAGE and underwent CTP within 24 h after onset of symptoms between January 2016 and October ... Among 27 patient admitted with iatrogenic CAGE, 15 patients underwent CTP within the designated timeframe and were included for imaging analysis. CTP showed perfusion deficits in all patients except o... CTP may show specific perfusion defects in patients with a clinical diagnosis of CAGE. This suggests that CTP may be supportive in diagnosing CAGE in cases where no intracerebral gas is seen on non-co...